Publications

Nature communications

TrialMatchAI: an end-to-end AI-powered clinical trial recommendation system to streamline patient-to-trial matching.

25-03-2026

Frontiers in pharmacology

Price transparency of cancer medicines: a crucial step towards informed pricing negotiations in the European region.

25-03-2026

Key Publication

Journal of the National Cancer Institute

Predicting long-term absolute risk of lung cancer in Hodgkin lymphoma patients.

23-03-2026

Science translational medicine

Patient-derived xenograft models of primary breast cancer for preclinical evaluation of neoadjuvant therapies.

18-03-2026

European radiology experimental

¹⁹F MRI radiomic features: in vitro and in vivo repeatability.

16-03-2026

Cancer research

C-Terminal Truncation and Fusion Partner Determine Oncogenicity of FGFR3.

16-03-2026

International journal of cancer

Olaparib for patients with tumors harboring alterations in homologous recombination repair genes: Results from the drug rediscovery protocol.

15-03-2026

European radiology experimental

Tumor morphology on CT radiomics is largely driven by the local anatomical environment, not the primary tumor type.

12-03-2026

Scientific data

A comprehensive European Colorectal Cancer Cohort dataset.

12-03-2026

European journal of cancer (Oxford, England : 1990)

Cancer-associated fibroblast signature and SMAD4 mutation in resistance to adjuvant chemotherapy in stage III colon cancer patients.

11-03-2026

Journal of gastrointestinal cancer

Quality of Life and Experiences of Patients with Gastrointestinal Stromal Tumors (GIST) on Imatinib Treatment.

10-03-2026

Journal of cancer survivorship : research and practice

Hospitalization for medical conditions in adolescent and young adult cancer survivors: a nationwide cohort study using the Netherlands Cancer Registry.

07-03-2026

Hepatology (Baltimore, Md.)

Aspartyl-tRNA synthetase 1 (DARS1) reshapes hepatocellular carcinoma proteome and promotes aggressiveness through noncanonical SAGA-MYC signaling modulation.

06-03-2026

Cell

CLIM-TIME links genetic cancer drivers to immune landscapes.

05-03-2026

Scientific reports

Evaluating mammographic density polygenic risk score for contralateral breast cancer risk prediction.

04-03-2026

Journal for immunotherapy of cancer

Where is the data? Delayed and chronic irAE surveillance and management after cessation of ICIs: expert insights from SITC on survivorship care and the need for long-term data.

03-03-2026

Public health genomics

A Value-Based Evaluation Framework for Guiding the Adoption and Scale-Up of Cancer Genomics Interventions.

02-03-2026

International journal of computer assisted radiology and surgery

Machine learning-based treatment outcome prediction in head and neck cancer using integrated noninvasive diagnostics.

01-03-2026

The Lancet. Oncology

Percutaneous hepatic perfusion combined with ipilimumab and nivolumab for metastatic uveal melanoma (CHOPIN): a single-centre, open-label, randomised, phase 2 trial.

01-03-2026

Nature cancer

Setting higher standards for reports of microbial species in human cancers.

01-03-2026

The Lancet. Oncology

MRI-based personalisation of neoadjuvant chemotherapy duration in HER2-positive early breast cancer (TRAIN-3): primary results from a multicentre, single-arm, phase 2 study.

01-03-2026

Abdominal radiology (New York)

Advancing MRI diagnostic practices in rectal cancer: exploring the impact of web-based multi-reader study participation.

01-03-2026

Nature medicine

Neoadjuvant ipilimumab plus nivolumab in melanoma: 5-year survival and biomarker analysis from the phase 2 PRADO-trial.

01-03-2026

Annals of surgical oncology

Rationales for Prehabilitation Programs in Patients Preparing for Oncologic Surgery: A Systematic Review.

01-03-2026

Psycho-oncology

Death Anxiety During the Last Year of Life in Patients With Advanced Cancer: Longitudinal Results From the eQuiPe Study.

01-03-2026

Nature

Regulatory grammar in human promoters uncovered by MPRA-based deep learning.

01-03-2026

Trends in genetics : TIG

Gene expression noise in development: genome-wide dynamics.

01-03-2026

Molecular diagnosis & therapy

Interlesional Heterogeneity of EGFR Mutations: A Systematic Review and Meta-analysis.

01-03-2026

Molecular & cellular proteomics : MCP

Cell-State-Specific Drug Responses are Associated With Differences in Signaling Network Wiring.

01-03-2026

International journal of clinical oncology

Pan-Asian subgroup analysis of EV-302/KEYNOTE-A39: a phase 3 study to evaluate enfortumab vedotin and pembrolizumab in patients with untreated advanced urothelial carcinoma.

01-03-2026

Nature medicine

Clinical development of cancer vaccines.

01-03-2026

Nature reviews. Clinical oncology

From detection to direction: ctDNA-guided personalized therapy for muscle-invasive bladder cancer.

01-03-2026

Clinical pharmacology and therapeutics

Reducing the Burden of Interaction Studies in Cancer Patients Using a Stable Isotopically Labeled Microtracer: A Proof-of-Concept Study with Alectinib.

01-03-2026

CPT: pharmacometrics & systems pharmacology

Semi-Physiological Population Pharmacokinetic Modeling of Oral and Intravenous Paracetamol to Quantify Presystemic Metabolism and Enterohepatic Recirculation.

01-03-2026

Health psychology review

Maintenance of lifestyle changes following lifestyle interventions in breast cancer survivors: a systematic literature review.

01-03-2026

The Lancet. Oncology

The OligoPanc project: an interdisciplinary expert consensus statement on oligometastatic pancreatic cancer.

01-03-2026

European journal of radiology

Corrigendum to "RECIST progression: Patterns among target, non-target, non-measurable and new lesions progression" [Eur. J. Radiol. 186 (2025) 112038].

01-03-2026

Annals of oncology : official journal of the European Society for Medical Oncology

Repertoire and clinical hierarchy of AR locus alterations in castration-resistant prostate cancer.

01-03-2026

Annals of surgical oncology

International Survey on Evidence for Index Lymph Node Surgery After Neoadjuvant Systemic Therapy for Stage III Melanoma.

01-03-2026

Journal of biomedical optics

Perspective on the current state of hyperspectral/multispectral imaging for minimally invasive surgery.

01-03-2026

Clinical breast cancer

Long-Term Health Issues of Adolescent and Young Adult Breast Cancer Survivors.

01-03-2026

Annals of surgical oncology

ASO Author Reflections: Reported rationales for the content of prehabilitation programs in the oncology setting.

01-03-2026

European journal of nuclear medicine and molecular imaging

[¹⁸F]FDG-PET/CT's change in total lesion glycolysis can accurately identify early response upon neoadjuvant immunotherapy prior to curative-intent surgery in cutaneous squamous cell carcinoma; MATISSE trial.

01-03-2026

Annals of surgical oncology

ASO Visual Abstract: Prognostic Value of Circulating Tumor DNA for Recurrence and Survival in Patients Undergoing Local Treatment for Initially Unresectable RAS/RAF Mutated Colorectal Cancer Liver Metastases.

01-03-2026

Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology

Are the CTV-to-PTV margins currently used in online adaptive radiotherapy for prostate cancer too large? The impact of the distribution of microscopic disease on treatment margin requirements.

01-03-2026

Nature cancer

Temporal and spatial composition of the tumor microenvironment predicts response to immune checkpoint inhibition in metastatic TNBC.

01-03-2026

Scientific reports

Effect of curcumin on the gut microbiota of patients with ulcerative colitis, Crohn's disease and healthy participants.

01-03-2026

Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology

Acute adverse events in the DESTINATION 1 trial: A prospective prostate SBRT dose de-escalation feasibility study.

01-03-2026

Technical innovations & patient support in radiation oncology

Direct-to-treatment MRI-guided prostate radiotherapy using a generic patient-agnostic reference plan.

01-03-2026

Nature chemistry

Monovalent pseudo-natural products supercharge degradation of IDO1 by its native E3 KLHDC3.

01-03-2026

TrialMatchAI: an end-to-end AI-powered clinical trial recommendation system to streamline patient-to-trial matching.

Price transparency of cancer medicines: a crucial step towards informed pricing negotiations in the European region.

Predicting long-term absolute risk of lung cancer in Hodgkin lymphoma patients.

Patient-derived xenograft models of primary breast cancer for preclinical evaluation of neoadjuvant therapies.

¹⁹F MRI radiomic features: in vitro and in vivo repeatability.

C-Terminal Truncation and Fusion Partner Determine Oncogenicity of FGFR3.

Olaparib for patients with tumors harboring alterations in homologous recombination repair genes: Results from the drug rediscovery protocol.

Tumor morphology on CT radiomics is largely driven by the local anatomical environment, not the primary tumor type.

A comprehensive European Colorectal Cancer Cohort dataset.

Cancer-associated fibroblast signature and SMAD4 mutation in resistance to adjuvant chemotherapy in stage III colon cancer patients.

Quality of Life and Experiences of Patients with Gastrointestinal Stromal Tumors (GIST) on Imatinib Treatment.

Hospitalization for medical conditions in adolescent and young adult cancer survivors: a nationwide cohort study using the Netherlands Cancer Registry.

Aspartyl-tRNA synthetase 1 (DARS1) reshapes hepatocellular carcinoma proteome and promotes aggressiveness through noncanonical SAGA-MYC signaling modulation.

CLIM-TIME links genetic cancer drivers to immune landscapes.

Evaluating mammographic density polygenic risk score for contralateral breast cancer risk prediction.

Where is the data? Delayed and chronic irAE surveillance and management after cessation of ICIs: expert insights from SITC on survivorship care and the need for long-term data.

A Value-Based Evaluation Framework for Guiding the Adoption and Scale-Up of Cancer Genomics Interventions.

Machine learning-based treatment outcome prediction in head and neck cancer using integrated noninvasive diagnostics.

Percutaneous hepatic perfusion combined with ipilimumab and nivolumab for metastatic uveal melanoma (CHOPIN): a single-centre, open-label, randomised, phase 2 trial.

Setting higher standards for reports of microbial species in human cancers.

MRI-based personalisation of neoadjuvant chemotherapy duration in HER2-positive early breast cancer (TRAIN-3): primary results from a multicentre, single-arm, phase 2 study.

Advancing MRI diagnostic practices in rectal cancer: exploring the impact of web-based multi-reader study participation.

Neoadjuvant ipilimumab plus nivolumab in melanoma: 5-year survival and biomarker analysis from the phase 2 PRADO-trial.

Rationales for Prehabilitation Programs in Patients Preparing for Oncologic Surgery: A Systematic Review.

Death Anxiety During the Last Year of Life in Patients With Advanced Cancer: Longitudinal Results From the eQuiPe Study.

Regulatory grammar in human promoters uncovered by MPRA-based deep learning.

Gene expression noise in development: genome-wide dynamics.

Interlesional Heterogeneity of EGFR Mutations: A Systematic Review and Meta-analysis.

Cell-State-Specific Drug Responses are Associated With Differences in Signaling Network Wiring.

Pan-Asian subgroup analysis of EV-302/KEYNOTE-A39: a phase 3 study to evaluate enfortumab vedotin and pembrolizumab in patients with untreated advanced urothelial carcinoma.

Clinical development of cancer vaccines.

From detection to direction: ctDNA-guided personalized therapy for muscle-invasive bladder cancer.

Reducing the Burden of Interaction Studies in Cancer Patients Using a Stable Isotopically Labeled Microtracer: A Proof-of-Concept Study with Alectinib.

Semi-Physiological Population Pharmacokinetic Modeling of Oral and Intravenous Paracetamol to Quantify Presystemic Metabolism and Enterohepatic Recirculation.

Maintenance of lifestyle changes following lifestyle interventions in breast cancer survivors: a systematic literature review.

The OligoPanc project: an interdisciplinary expert consensus statement on oligometastatic pancreatic cancer.

Corrigendum to "RECIST progression: Patterns among target, non-target, non-measurable and new lesions progression" [Eur. J. Radiol. 186 (2025) 112038].

Repertoire and clinical hierarchy of AR locus alterations in castration-resistant prostate cancer.

International Survey on Evidence for Index Lymph Node Surgery After Neoadjuvant Systemic Therapy for Stage III Melanoma.

Perspective on the current state of hyperspectral/multispectral imaging for minimally invasive surgery.

Long-Term Health Issues of Adolescent and Young Adult Breast Cancer Survivors.

ASO Author Reflections: Reported rationales for the content of prehabilitation programs in the oncology setting.

[18F]FDG-PET/CT's change in total lesion glycolysis can accurately identify early response upon neoadjuvant immunotherapy prior to curative-intent surgery in cutaneous squamous cell carcinoma; MATISSE trial.

ASO Visual Abstract: Prognostic Value of Circulating Tumor DNA for Recurrence and Survival in Patients Undergoing Local Treatment for Initially Unresectable RAS/RAF Mutated Colorectal Cancer Liver Metastases.

Are the CTV-to-PTV margins currently used in online adaptive radiotherapy for prostate cancer too large? The impact of the distribution of microscopic disease on treatment margin requirements.

Temporal and spatial composition of the tumor microenvironment predicts response to immune checkpoint inhibition in metastatic TNBC.

Effect of curcumin on the gut microbiota of patients with ulcerative colitis, Crohn's disease and healthy participants.

Acute adverse events in the DESTINATION 1 trial: A prospective prostate SBRT dose de-escalation feasibility study.

Direct-to-treatment MRI-guided prostate radiotherapy using a generic patient-agnostic reference plan.

Monovalent pseudo-natural products supercharge degradation of IDO1 by its native E3 KLHDC3.

This site uses cookies

[¹⁸F]FDG-PET/CT's change in total lesion glycolysis can accurately identify early response upon neoadjuvant immunotherapy prior to curative-intent surgery in cutaneous squamous cell carcinoma; MATISSE trial.